"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","treatment_protocol_ch1","growth_protocol_ch1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","data_processing","platform_id","contact_name","contact_email","contact_institute","contact_address","contact_city","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","cell line:ch1","cell type:ch1"
"GSM1052615","A375 cells 24h Control rep1","GSM1052615","Public on May 20 2014","Dec 12 2012","May 20 2014","RNA","1","A375 melanoma cells treated with vehicle (0.1% DMSO) batch A","Homo sapiens","cell type: Melanoma cell line","cell line: A375","Cells were seeded in dup[licate 10cm dishes at 1,000,000 cells per dish and incubated for 24h then cells were treated with vehicle (0.1% DMSO) or Vemurafenib (Vem; PLX4032) for a further 24h.","A375 human melanoma cells grown in a monolayer in a 37°C humidified 5%CO2 incubator. Cells were grown in RPMI 1640 + HEPES containing 10% FBS, 2 mM L-alanyl-L-glutamine, 1% penicillin/streptomycin and 250 ng/ml amphotericin B","total RNA","Total RNA was extracted using a Qiagen miRNeasy Mini kit according to the manufacturer's protocol.","biotin","Biotinylated cRNA was prepared from an input of 250ng RNA using an Ambion WT kit followed by the Affymetrix terminal labelling kit according to the manufacturer's instructions.","9606","5μg of fragmented, labeled cRNA was hybridized at 45°C for 16h onto GeneChip® 1.0 ST human gene arrays then washed and stained using the Affymetrix GeneChip Fluidics Station 450","GeneChips were scanned using an Affymetrix 3000 7G scanner","Gene expression data from A375 melanoma cells treated with vehicle control (0.1% DMSO)","Raw data were RMA normalized after which differentially expressed genes were detected using a 2-way ANOVA using Partek software. The batch date of the different replicates was controlled for and the log fold change between control and Vem-treated samples was estimated. Normalized data was also subjected to gene set enrichment analysis (provided online by the Broad Institute) using c2 curated gene sets (Molecular signatures database v3.1) to identify enrichment of entire gene sets in either the control of Vem-treated samples","GPL6244","Tiffany,Joy,Parmenter","tiffanyparmenter@gmail.com","Peter MacCallum Cancer Centre","1 St Andrews Pl","East Melbourne","3002","Australia","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1052nnn/GSM1052615/suppl/GSM1052615_TP_A3.C.A_HuGene-1_0-st-v1_.CEL.gz","33297"," A375"," Melanoma cell line"
"GSM1052616","A375 cells 24h Control rep2","GSM1052616","Public on May 20 2014","Dec 12 2012","May 20 2014","RNA","1","A375 melanoma cells treated with vehicle (0.1% DMSO)","Homo sapiens","cell type: Melanoma cell line","cell line: A375","Cells were seeded in dup[licate 10cm dishes at 1,000,000 cells per dish and incubated for 24h then cells were treated with vehicle (0.1% DMSO) or Vemurafenib (Vem; PLX4032) for a further 24h.","A375 human melanoma cells grown in a monolayer in a 37°C humidified 5%CO2 incubator. Cells were grown in RPMI 1640 + HEPES containing 10% FBS, 2 mM L-alanyl-L-glutamine, 1% penicillin/streptomycin and 250 ng/ml amphotericin B","total RNA","Total RNA was extracted using a Qiagen miRNeasy Mini kit according to the manufacturer's protocol.","biotin","Biotinylated cRNA was prepared from an input of 250ng RNA using an Ambion WT kit followed by the Affymetrix terminal labelling kit according to the manufacturer's instructions.","9606","5μg of fragmented, labeled cRNA was hybridized at 45°C for 16h onto GeneChip® 1.0 ST human gene arrays then washed and stained using the Affymetrix GeneChip Fluidics Station 450","GeneChips were scanned using an Affymetrix 3000 7G scanner","Gene expression data from A375 melanoma cells treated with vehicle control (0.1% DMSO)","Raw data were RMA normalized after which differentially expressed genes were detected using a 2-way ANOVA using Partek software. The batch date of the different replicates was controlled for and the log fold change between control and Vem-treated samples was estimated. Normalized data was also subjected to gene set enrichment analysis (provided online by the Broad Institute) using c2 curated gene sets (Molecular signatures database v3.1) to identify enrichment of entire gene sets in either the control of Vem-treated samples","GPL6244","Tiffany,Joy,Parmenter","tiffanyparmenter@gmail.com","Peter MacCallum Cancer Centre","1 St Andrews Pl","East Melbourne","3002","Australia","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1052nnn/GSM1052616/suppl/GSM1052616_TP_A3.C.B_HuGene-1_0-st-v1_.CEL.gz","33297"," A375"," Melanoma cell line"
"GSM1052617","A375 cells 24h Control rep3","GSM1052617","Public on May 20 2014","Dec 12 2012","May 20 2014","RNA","1","A375 melanoma cells treated with vehicle (0.1% DMSO)","Homo sapiens","cell type: Melanoma cell line","cell line: A375","Cells were seeded in dup[licate 10cm dishes at 1,000,000 cells per dish and incubated for 24h then cells were treated with vehicle (0.1% DMSO) or Vemurafenib (Vem; PLX4032) for a further 24h.","A375 human melanoma cells grown in a monolayer in a 37°C humidified 5%CO2 incubator. Cells were grown in RPMI 1640 + HEPES containing 10% FBS, 2 mM L-alanyl-L-glutamine, 1% penicillin/streptomycin and 250 ng/ml amphotericin B","total RNA","Total RNA was extracted using a Qiagen miRNeasy Mini kit according to the manufacturer's protocol.","biotin","Biotinylated cRNA was prepared from an input of 250ng RNA using an Ambion WT kit followed by the Affymetrix terminal labelling kit according to the manufacturer's instructions.","9606","5μg of fragmented, labeled cRNA was hybridized at 45°C for 16h onto GeneChip® 1.0 ST human gene arrays then washed and stained using the Affymetrix GeneChip Fluidics Station 450","GeneChips were scanned using an Affymetrix 3000 7G scanner","Gene expression data from A375 melanoma cells treated with vehicle control (0.1% DMSO)","Raw data were RMA normalized after which differentially expressed genes were detected using a 2-way ANOVA using Partek software. The batch date of the different replicates was controlled for and the log fold change between control and Vem-treated samples was estimated. Normalized data was also subjected to gene set enrichment analysis (provided online by the Broad Institute) using c2 curated gene sets (Molecular signatures database v3.1) to identify enrichment of entire gene sets in either the control of Vem-treated samples","GPL6244","Tiffany,Joy,Parmenter","tiffanyparmenter@gmail.com","Peter MacCallum Cancer Centre","1 St Andrews Pl","East Melbourne","3002","Australia","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1052nnn/GSM1052617/suppl/GSM1052617_TP_A3.C.C_HuGene-1_0-st-v1_.CEL.gz","33297"," A375"," Melanoma cell line"
"GSM1052618","A375 cells 24h Vemurafenib rep1","GSM1052618","Public on May 20 2014","Dec 12 2012","May 20 2014","RNA","1","A375 melanoma cells treated with vemurafenib","Homo sapiens","cell type: Melanoma cell line","cell line: A375","Cells were seeded in dup[licate 10cm dishes at 1,000,000 cells per dish and incubated for 24h then cells were treated with vehicle (0.1% DMSO) or Vemurafenib (Vem; PLX4032) for a further 24h.","A375 human melanoma cells grown in a monolayer in a 37°C humidified 5%CO2 incubator. Cells were grown in RPMI 1640 + HEPES containing 10% FBS, 2 mM L-alanyl-L-glutamine, 1% penicillin/streptomycin and 250 ng/ml amphotericin B","total RNA","Total RNA was extracted using a Qiagen miRNeasy Mini kit according to the manufacturer's protocol.","biotin","Biotinylated cRNA was prepared from an input of 250ng RNA using an Ambion WT kit followed by the Affymetrix terminal labelling kit according to the manufacturer's instructions.","9606","5μg of fragmented, labeled cRNA was hybridized at 45°C for 16h onto GeneChip® 1.0 ST human gene arrays then washed and stained using the Affymetrix GeneChip Fluidics Station 450","GeneChips were scanned using an Affymetrix 3000 7G scanner","Gene expression data from A375 melanoma cells treated with 10 μM vemurafenib","Raw data were RMA normalized after which differentially expressed genes were detected using a 2-way ANOVA using Partek software. The batch date of the different replicates was controlled for and the log fold change between control and Vem-treated samples was estimated. Normalized data was also subjected to gene set enrichment analysis (provided online by the Broad Institute) using c2 curated gene sets (Molecular signatures database v3.1) to identify enrichment of entire gene sets in either the control of Vem-treated samples","GPL6244","Tiffany,Joy,Parmenter","tiffanyparmenter@gmail.com","Peter MacCallum Cancer Centre","1 St Andrews Pl","East Melbourne","3002","Australia","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1052nnn/GSM1052618/suppl/GSM1052618_TP_A3.V.A_HuGene-1_0-st-v1_.CEL.gz","33297"," A375"," Melanoma cell line"
"GSM1052619","A375 cells 24h Vemurafenib rep2","GSM1052619","Public on May 20 2014","Dec 12 2012","May 20 2014","RNA","1","A375 melanoma cells treated with vemurafenib","Homo sapiens","cell type: Melanoma cell line","cell line: A375","Cells were seeded in dup[licate 10cm dishes at 1,000,000 cells per dish and incubated for 24h then cells were treated with vehicle (0.1% DMSO) or Vemurafenib (Vem; PLX4032) for a further 24h.","A375 human melanoma cells grown in a monolayer in a 37°C humidified 5%CO2 incubator. Cells were grown in RPMI 1640 + HEPES containing 10% FBS, 2 mM L-alanyl-L-glutamine, 1% penicillin/streptomycin and 250 ng/ml amphotericin B","total RNA","Total RNA was extracted using a Qiagen miRNeasy Mini kit according to the manufacturer's protocol.","biotin","Biotinylated cRNA was prepared from an input of 250ng RNA using an Ambion WT kit followed by the Affymetrix terminal labelling kit according to the manufacturer's instructions.","9606","5μg of fragmented, labeled cRNA was hybridized at 45°C for 16h onto GeneChip® 1.0 ST human gene arrays then washed and stained using the Affymetrix GeneChip Fluidics Station 450","GeneChips were scanned using an Affymetrix 3000 7G scanner","Gene expression data from A375 melanoma cells treated with 10 μM vemurafenib","Raw data were RMA normalized after which differentially expressed genes were detected using a 2-way ANOVA using Partek software. The batch date of the different replicates was controlled for and the log fold change between control and Vem-treated samples was estimated. Normalized data was also subjected to gene set enrichment analysis (provided online by the Broad Institute) using c2 curated gene sets (Molecular signatures database v3.1) to identify enrichment of entire gene sets in either the control of Vem-treated samples","GPL6244","Tiffany,Joy,Parmenter","tiffanyparmenter@gmail.com","Peter MacCallum Cancer Centre","1 St Andrews Pl","East Melbourne","3002","Australia","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1052nnn/GSM1052619/suppl/GSM1052619_TP_A3.V.B_HuGene-1_0-st-v1_.CEL.gz","33297"," A375"," Melanoma cell line"
"GSM1052620","A375 cells 24h Vemurafenib rep3","GSM1052620","Public on May 20 2014","Dec 12 2012","May 20 2014","RNA","1","A375 melanoma cells treated with vemurafenib","Homo sapiens","cell type: Melanoma cell line","cell line: A375","Cells were seeded in dup[licate 10cm dishes at 1,000,000 cells per dish and incubated for 24h then cells were treated with vehicle (0.1% DMSO) or Vemurafenib (Vem; PLX4032) for a further 24h.","A375 human melanoma cells grown in a monolayer in a 37°C humidified 5%CO2 incubator. Cells were grown in RPMI 1640 + HEPES containing 10% FBS, 2 mM L-alanyl-L-glutamine, 1% penicillin/streptomycin and 250 ng/ml amphotericin B","total RNA","Total RNA was extracted using a Qiagen miRNeasy Mini kit according to the manufacturer's protocol.","biotin","Biotinylated cRNA was prepared from an input of 250ng RNA using an Ambion WT kit followed by the Affymetrix terminal labelling kit according to the manufacturer's instructions.","9606","5μg of fragmented, labeled cRNA was hybridized at 45°C for 16h onto GeneChip® 1.0 ST human gene arrays then washed and stained using the Affymetrix GeneChip Fluidics Station 450","GeneChips were scanned using an Affymetrix 3000 7G scanner","Gene expression data from A375 melanoma cells treated with 10 μM vemurafenib","Raw data were RMA normalized after which differentially expressed genes were detected using a 2-way ANOVA using Partek software. The batch date of the different replicates was controlled for and the log fold change between control and Vem-treated samples was estimated. Normalized data was also subjected to gene set enrichment analysis (provided online by the Broad Institute) using c2 curated gene sets (Molecular signatures database v3.1) to identify enrichment of entire gene sets in either the control of Vem-treated samples","GPL6244","Tiffany,Joy,Parmenter","tiffanyparmenter@gmail.com","Peter MacCallum Cancer Centre","1 St Andrews Pl","East Melbourne","3002","Australia","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1052nnn/GSM1052620/suppl/GSM1052620_TP_A3.V.C_HuGene-1_0-st-v1_.CEL.gz","33297"," A375"," Melanoma cell line"
